Tuesday, November 22, 2005
Growers Research Group and LSBC ink licensing deal
Growers Research Group has:
|
entered into a research license and option agreement centered on LSBC's proprietary GENEWARE® plant gene expression technology. The license provides GRG with access to a key technology, developed internally and extensively patented by LSBC, to accelerate development of new products for use in agriculture.My interpretation: LSBC has passed the development of their lysozyme project over to GRC in an attempt to further focus their business model (production of therapeutic recombinant enzymes). I suspect that they don't want to commit what resources they have left to the progression of this project. This is pretty much backed up by a quote from Greg Pogue, Vice President, Research and Development:
"By licensing a technology asset in a field of use which is no longer part of our core portfolio, we generate value for LSBC while focusing our efforts in our core business, namely, the development of novel and follow-on plant-made biopharmaceuticals,"
